Roche Holding AG (OTCMKTS:RHHBY) Given Average Rating of “Hold” by Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned a consensus rating of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $57.00.

Several brokerages have issued reports on RHHBY. JPMorgan Chase & Co. upgraded Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “sell” rating to a “hold” rating in a research report on Tuesday, November 11th. The Goldman Sachs Group raised Roche from a “sell” rating to a “hold” rating in a research note on Thursday, January 15th. Citigroup initiated coverage on shares of Roche in a report on Tuesday, January 27th. They set a “buy” rating for the company. Finally, HSBC reissued a “buy” rating and issued a $57.00 target price on shares of Roche in a research note on Wednesday, December 10th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Curio Wealth LLC bought a new stake in shares of Roche in the third quarter worth $25,000. Oakworth Capital Inc. acquired a new position in Roche during the third quarter worth approximately $57,000. First Horizon Advisors Inc. increased its holdings in shares of Roche by 81.2% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company’s stock worth $75,000 after acquiring an additional 826 shares during the last quarter. Salomon & Ludwin LLC increased its holdings in shares of Roche by 256.6% in the third quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock valued at $129,000 after purchasing an additional 2,053 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC acquired a new position in Roche in the 3rd quarter valued at about $201,000.

Roche Stock Down 1.0%

Shares of RHHBY stock opened at $57.11 on Thursday. Roche has a 12-month low of $34.75 and a 12-month high of $58.40. The firm has a 50-day moving average price of $52.85 and a 200 day moving average price of $46.13. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.29 and a quick ratio of 1.02.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.